CLSI M22-A3 — Overview CLSI M22-A3 is the third edition of a Clinical and Laboratory Standards Institute (CLSI) guideline titled "Methods for Antimicrobial Disk Susceptibility Tests" (note: CLSI document codes sometimes vary; M22 series specifically covers antimicrobial susceptibility testing methods and interpretive criteria). This edition updates procedures, quality-control recommendations, and interpretive criteria for disk diffusion testing of bacteria to ensure reliable, reproducible susceptibility results across clinical microbiology laboratories. Purpose and scope
Standardizes disk diffusion procedures for testing aerobic bacteria. Gives specific instructions on media, inoculum preparation, incubation conditions, disk content, and zone measurement. Provides quality-control (QC) strains and acceptable QC ranges to monitor test performance. Addresses interpretation of inhibition zone diameters for categorizing organisms as susceptible (S), intermediate (I), or resistant (R).
Key contents
Required materials and reagents (e.g., Mueller-Hinton agar specifications, antibiotic disk potencies). Step-by-step testing workflow: inoculum density (0.5 McFarland standard), plate inoculation, disk application, incubation (temperature and atmosphere), and measurement of inhibition zones. Troubleshooting guidance for common errors (inoculum too heavy/light, agar depth variations, incorrect disk potency, incubation problems). Quality control procedures, recommended QC organisms (e.g., Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923) and acceptable zone diameter ranges. Updates on interpretive criteria and breakpoints aligned with current clinical evidence and pharmacodynamics where applicable. Recommendations for reporting and clinical interpretation, including limitations of disk diffusion for certain organism–drug combinations. clsi m22a3 pdf
Practical implications
Adoption of CLSI M22-A3 improves inter-laboratory consistency and diagnostic accuracy. Ensures laboratories meet regulatory and accreditation standards by following validated methods. Helps clinicians select appropriate antimicrobial therapy based on standardized susceptibility categories.
Accessing the PDF CLSI documents like M22-A3 are copyrighted and typically distributed by CLSI as purchasable standards. Many laboratories obtain them through institutional subscriptions, library access, or by purchase from the CLSI website or authorized distributors. Short summary CLSI M22-A3 provides standardized, evidence-based procedures and QC guidance for antimicrobial disk diffusion susceptibility testing, with updated interpretive criteria to support accurate clinical microbiology reporting. If you need a focused summary (e.g., QC ranges, step-by-step protocol, or differences from the prior edition), specify which section and I’ll generate a concise extract. CLSI M22-A3 — Overview CLSI M22-A3 is the
The most significant feature of the CLSI M22-A3 document is the expanded list of "exempt" media , which significantly reduces the workload for microbiology laboratories. By classifying certain commercially prepared media as exempt, the standard removes the requirement for end-users to perform redundant quality control (QC) retesting on media with proven reliability. Clinical & Laboratory Standards Institute | CLSI Key Features of CLSI M22-A3 Expansion of Exempt Media : Based on extensive surveys by the College of American Pathologists (CAP), this version added 27 additional media types to the exempt list, totaling 51 exempt media. New Failure Rate Cutoff : The acceptable extrapolated failure rate for media to qualify as exempt was increased from 0.3% to 0.5% Defined Responsibilities : It explicitly outlines the specific quality assurance roles for manufacturers, distributors, and users Simplified QC Protocols : The standard provides streamlined procedures for maintaining quality control organisms and updated incubation conditions for testing. Fastidious Organism Guidance : It includes new recommendations for the quality control of media used to grow "fastidious" (difficult to grow) organisms. Clinical & Laboratory Standards Institute | CLSI Why This Matters for Laboratories The "exempt" status means that if a laboratory receives a lot of media from a commercial manufacturer that has already performed QC (evidenced by a Certificate of Quality), the lab only needs to perform physical inspections (checking for cracks, contamination, or hemolysis) rather than full organism-based performance testing. This saves labs substantial time and money while maintaining high safety standards. ANSI Webstore You can purchase or view more details on the official CLSI M22-A3 product page or access a preview through the ANSI Webstore specific media types are included in the 27 newly exempt categories?
CLSI M22-A3, "Quality Control for Commercially Prepared Microbiological Culture Media," establishes protocols for testing ready-to-use media, emphasizing an acceptable failure rate of ≤0.5% for exempt media. While it defines responsibilities for QC, U.S. laboratories have transitioned from these exemptions to Individualized Quality Control Plans (IQCP). Purchase the document through the CLSI Shop .
The CLSI M22-A3 standard, titled "Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard—Third Edition," provides essential quality assurance procedures for both manufacturers and laboratory users. Core Content Overview The document focuses on ensuring the reliability of ready-to-use culture media to prevent unnecessary retesting by laboratories. Key sections typically include: Manufacturer Quality Practices : Detailed requirements for controlling contamination, physical imperfections (e.g., agar thickness, bubbles), and the use of working control cultures. User Quality Assurance : Guidelines for visual inspection upon receipt (e.g., checking for cracked plates, dehydration, or hemolysis in blood media) and remedial actions for deficiencies. Exempt Media List (Table 2) : A critical section identifying specific media that do not require routine user quality control because they have a proven failure rate of . Operational Standards : Procedures for packaging, transport, and storage to maintain media shelf life. Testing Protocols : Guidelines for preparing inoculum (such as matching a 0.5 McFarland standard) and isolation streaking methods for quality verification. Key Specifications Acceptable Failure Rate : The threshold for an acceptable failure rate in a batch/lot is defined as (e.g., no more than 5 out of 1000 units with random defects). Physical Inspection Parameters : Users are expected to examine at least 10 units per lot for issues like unequal filling, precipitates, or detached agar. Access and Availability The full standard is a copyrighted document and can be purchased from the CLSI Shop or the ANSI Webstore . For laboratories building an Individualized Quality Control Plan (IQCP) , templates following M22-A3 guidelines are often provided by organizations like the American Society for Microbiology (ASM) . If you'd like, I can help you: Identify which specific media types are exempt from retesting. Draft a visual inspection checklist based on these standards. Understand how to incorporate these guidelines into an IQCP . Let me know which area you'd like to explore further . Key contents Required materials and reagents (e
The CLSI M22-A3 standard, titled "Quality Control for Commercially Prepared Microbiological Culture Media," is a critical guideline used by clinical laboratories to streamline the validation of the growth media they use for diagnostic testing. What is CLSI M22-A3? Published by the Clinical and Laboratory Standards Institute (CLSI) , this document provides specific protocols for the quality control (QC) of commercially manufactured microbiological culture media. Its primary goal is to ensure that the media used in laboratories is capable of supporting the growth of target pathogens while remaining sterile and chemically stable. The "Exempt" vs. "Non-Exempt" Classification One of the most significant contributions of M22-A3 is the classification of media into two categories based on their historical failure rates. This system allows laboratories to reduce unnecessary testing, saving both time and resources: Exempt Media : These are common, highly stable media types (like Blood Agar or MacConkey Agar) that have a proven track record of high quality from manufacturers. For these, laboratories can rely on the manufacturer's QC certificate rather than performing full in-house retesting, provided the lab verifies the storage conditions and physical integrity. Non-Exempt Media : These are media types with higher failure rates or those used for fastidious organisms (like Chocolate Agar or Campylobacter media). Laboratories must perform full QC testing on every new lot or shipment of these media. Key Quality Control Parameters Under the M22-A3 guidelines, a comprehensive QC check involves several verification steps: Sterility : Ensuring no unintended microbial growth occurs during incubation. Growth Performance : Using specific "ATCC" (American Type Culture Collection) control strains to confirm the media supports expected growth. Selectivity/Inhibition : Confirming that selective media successfully inhibits the growth of non-target organisms. Biochemical Response : Ensuring differential media produces the correct color changes or reactions (e.g., lactose fermentation on MAC). Physical Integrity : Checking for correct pH, moisture levels, color, and lack of hemolysis (for blood-based media). Why the PDF Version is Essential For laboratory managers and microbiology leads, having the CLSI M22-A3 PDF is necessary for compliance with accreditation bodies like CAP (College of American Pathologists) or The Joint Commission . It provides the specific "Table 1," which lists exactly which media are exempt and which organisms must be used for testing non-exempt batches. Implementation Best Practices Maintain Records : Keep all manufacturer QC certificates and in-house testing logs organized for inspection. Verify Shipping : Always check the temperature indicators and physical state of the media upon arrival. Update Protocols : Ensure your Lab SOPs reflect the current M22-A3 standards to avoid "over-testing" exempt media. AI responses may include mistakes. Learn more
The CLSI M22-A3 (3rd Edition) document, "Quality Control for Commercially Prepared Microbiological Culture Media," provides guidelines for the QC testing of microbiological culture media, focusing on reducing testing for low-failure "exempt" media. It classifies media into exempt and non-exempt categories, detailing specific QC parameters and the division of responsibility between manufacturers and clinical laboratories. The standard is a copyrighted publication of the Clinical and Laboratory Standards Institute (CLSI) and can be purchased on their official website or accessed through institutional subscriptions.